TRIAL DETAIL
A Study of Avelumab In Combination With Axitinib in Patients With Unresectable/Metastatic Gastrointestinal Stromal Tumor After Failure of Standard Therapy (AXAGIST)
Drug: |
||||
|---|---|---|---|---|
Trial Name: |
A Study of Avelumab In Combination With Axitinib in Patients With Unresectable/Metastatic Gastrointestinal Stromal Tumor After Failure of Standard Therapy (AXAGIST) |
|||
NCT#: |
||||
Conditions: |
Gastrointestinal Stromal Tumor |
|||
Status: |
Recruiting |
|||
Phase: |
2 |
Start Date 04/30/2019 |
Age of Trial (yrs) 3.9 |
|
Treatment Phase: |
Gleevec-resistant |
|||
Drug Category: |
PD-L1 + KIT inhibitor |
|||
Strategy: |
||||
Trial Type: |
Specifically GIST and only GIST |
|||
Other Protocol IDs: |
AXAGIST
|
|||
Sponsor: |
Maria Sklodowska-Curie Institute - Oncology Center |
|||
Patient Contact: |
Elzbieta Bylina, MSc
22546 21 03 ext 0048
elzbieta.bylina@coi.pl
Katarzyna Kozak, MD
225462172 ext 0048
katarzyna.kozak@coi.pl |
|||
Contact email: |
||||
Contact Phone: |
||||
Randomized: |
||||
IV or Oral: |
Oral
Intravenous |
|||
Trial Notes: |
||||
Trial Links |
Trial Results |
Drug Information |
Trial Sites
Name |
Address |
City |
State |
Zip |
Country |
Warsaw |
Poland |